These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 8627612)
21. Mechanism-based development of new antimalarials: synthesis of derivatives of artemisinin attached to iron chelators. Kamchonwongpaisan S; Paitayatat S; Thebtaranonth Y; Wilairat P; Yuthavong Y J Med Chem; 1995 Jun; 38(13):2311-6. PubMed ID: 7608896 [TBL] [Abstract][Full Text] [Related]
22. Novel ferrocenic artemisinin derivatives: synthesis, in vitro antimalarial activity and affinity of binding with ferroprotoporphyrin IX. Delhaes L; Blot C; Berry L; Maciejewski LA; Camus D; Brocard JS; Dive D Bioorg Med Chem; 2000 Dec; 8(12):2739-45. PubMed ID: 11131165 [TBL] [Abstract][Full Text] [Related]
23. Antimalarial, antiproliferative, and antitumor activities of artemisinin-derived, chemically robust, trioxane dimers. Posner GH; Ploypradith P; Parker MH; O'Dowd H; Woo SH; Northrop J; Krasavin M; Dolan P; Kensler TW; Xie S; Shapiro TA J Med Chem; 1999 Oct; 42(21):4275-80. PubMed ID: 10543871 [TBL] [Abstract][Full Text] [Related]
24. Novel, potent, semisynthetic antimalarial carba analogues of the first-generation 1,2,4-trioxane artemether. O'Neill PM; Searle NL; Kan KW; Storr RC; Maggs JL; Ward SA; Raynes K; Park BK J Med Chem; 1999 Dec; 42(26):5487-93. PubMed ID: 10639291 [TBL] [Abstract][Full Text] [Related]
25. Orally active, hydrolytically stable, semisynthetic, antimalarial trioxanes in the artemisinin family. Posner GH; Parker MH; Northrop J; Elias JS; Ploypradith P; Xie S; Shapiro TA J Med Chem; 1999 Jan; 42(2):300-4. PubMed ID: 9925735 [TBL] [Abstract][Full Text] [Related]
26. Antimalarial activity of artemisinin (qinghaosu) and related trioxanes: mechanism(s) of action. Cumming JN; Ploypradith P; Posner GH Adv Pharmacol; 1997; 37():253-97. PubMed ID: 8891104 [No Abstract] [Full Text] [Related]
27. Antimalarial activity of new dihydroartemisinin derivatives. 7. 4-(p-substituted phenyl)-4(R or S)-[10(alpha or beta)-dihydroartemisininoxy]butyric acids. Lin AJ; Zikry AB; Kyle DE J Med Chem; 1997 Apr; 40(9):1396-400. PubMed ID: 9135037 [TBL] [Abstract][Full Text] [Related]
28. Stereoselective synthesis and antimalarial activity of alpha-artelinic acid from artemisinin. Vishwakarma RA; Mehrotra R; Tripathi R; Dutta GP J Nat Prod; 1992 Aug; 55(8):1142-4. PubMed ID: 1431937 [TBL] [Abstract][Full Text] [Related]
29. Artemisone--a highly active antimalarial drug of the artemisinin class. Haynes RK; Fugmann B; Stetter J; Rieckmann K; Heilmann HD; Chan HW; Cheung MK; Lam WL; Wong HN; Croft SL; Vivas L; Rattray L; Stewart L; Peters W; Robinson BL; Edstein MD; Kotecka B; Kyle DE; Beckermann B; Gerisch M; Radtke M; Schmuck G; Steinke W; Wollborn U; Schmeer K; Römer A Angew Chem Int Ed Engl; 2006 Mar; 45(13):2082-8. PubMed ID: 16444785 [No Abstract] [Full Text] [Related]
30. Mechanism-based design, synthesis, and in vitro antimalarial testing of new 4-methylated trioxanes structurally related to artemisinin: the importance of a carbon-centered radical for antimalarial activity. Posner GH; Oh CH; Wang D; Gerena L; Milhous WK; Meshnick SR; Asawamahasadka W J Med Chem; 1994 Apr; 37(9):1256-8. PubMed ID: 8176702 [No Abstract] [Full Text] [Related]
35. Chemistry of artemisinin: an overview. Webster HK; Lehnert EK Trans R Soc Trop Med Hyg; 1994 Jun; 88 Suppl 1():S27-9. PubMed ID: 8053019 [TBL] [Abstract][Full Text] [Related]
36. Synthesis and antimalarial activity of (+)-deoxoartemisinin. Jung M; Li X; Bustos DA; elSohly HN; McChesney JD; Milhous WK J Med Chem; 1990 May; 33(5):1516-8. PubMed ID: 2329574 [TBL] [Abstract][Full Text] [Related]
37. Artemisinin antimalarials: mechanisms of action and resistance. Meshnick SR Med Trop (Mars); 1998; 58(3 Suppl):13-7. PubMed ID: 10212891 [TBL] [Abstract][Full Text] [Related]
39. Artemisinin and the antimalarial endoperoxides: from herbal remedy to targeted chemotherapy. Meshnick SR; Taylor TE; Kamchonwongpaisan S Microbiol Rev; 1996 Jun; 60(2):301-15. PubMed ID: 8801435 [TBL] [Abstract][Full Text] [Related]
40. Kinetics of iron-mediated artemisinin degradation: effect of solvent composition and iron salt. Creek DJ; Chiu FC; Prankerd RJ; Charman SA; Charman WN J Pharm Sci; 2005 Aug; 94(8):1820-9. PubMed ID: 15986470 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]